In a remarkable milestone, India’s yearly drug and pharmaceutical exports reached an all-time high of $30 billion in Fiscal Year 2025, fueled by a 31 percent increase compared to the previous year in March...
Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering
Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical technology development, has entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda...
To protect their growth in turbidity, Indian pharmaceutical companies, especially the smaller and mid-sized players, are now swinging their attention to...
Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...
Alembic Pharmaceuticals Limited (Alembic) has received from the U.S. Food and Drug Administration (U.S. FDA), final approval for its ANDA application for...
The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o
The Union Health Ministry hereby prohibits the use of cold FDC Chlorpheniramine Maleate 2 mg and Phenylephrine Hydrochloride 5 mg per ml drops in children below the...
The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....
India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation